To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC

Clinical trial NCT00432185 · COMPLETED

Trial details

NCT number: NCT00432185
Sponsor: Peplin
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Superficial Basal Cell Carcinoma

Start date: 2007-02-01
Primary completion: 2010-03-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.